Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-19-123703
Filing Date
2019-04-29
Accepted
2019-04-29 07:27:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRER14A d660374dprer14a.htm PRER14A 1005255
2 GRAPHIC g660374g21w10.jpg GRAPHIC 33374
3 GRAPHIC g660374g38l86.jpg GRAPHIC 23213
4 GRAPHIC g660374g47k82.jpg GRAPHIC 25755
5 GRAPHIC g660374g54t09.jpg GRAPHIC 22635
6 GRAPHIC g660374g77a13.jpg GRAPHIC 23954
  Complete submission text file 0001193125-19-123703.txt   1183877
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37923 | Film No.: 19773704
SIC: 2836 Biological Products, (No Diagnostic Substances)